EnzydaY

62, 63 The inconsistency in the data on time to surgery is further compounded by the lack of uniformly measured time intervals e clomid for pct Non steroidal SERM, prodrug of Afimoxifene Endoxifen 30 to 100x more active at estrogen receptor than Tamoxifen itself, agonist in bone and uterus, antagonist in breast, used for breast cancer treatment anti estrogen antagonist, increase in 5 year survival rate after surgery in estrogen receptor positive carcinomas, decrease incidence of cancer in the contralateral breast